Anticorps Recombinant de lapin anti-CD22
CD22 Recombinant Antibody for IF/ICC, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
souris
Applications
IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
250078E8
N° de cat : 86128-2-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
86128-2-PBS cible CD22 dans les applications de IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons souris
| Réactivité | souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | CD22 Protéine recombinante Eg1324 |
| Nom complet | CD22 antigen |
| Masse moléculaire calculée | 97kDa |
| Numéro d’acquisition GenBank | NM_001043317.2 |
| Symbole du gène | Cd22 |
| Identification du gène (NCBI) | 12483 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
CD22, also known as Siglec-2 (sialic acid binding Ig-like lectin 2) or BL-CAM (B-lymphocyte cell adhesion molecule), is a 130-140 kDa, B-cell restricted, type I transmembrane glycoprotein belonging to the immunoglobulin gene superfamily. The expression of CD22 is developmentally regulated. It is expressed at low levels in the cytoplasm of pro-B and pre-B cells and present on the cell surface only at mature stages of B-cell differentiation. Cell surface expression is lost during terminal differentiation into plasma cell and after B-cell activation. CD22 is an inhibitory receptor for B-cell receptor (BCR) signalling, preferentially binds to alpha-2,6-linked sialic acid and mediates B-cell B-cell interactions. It plays a crucial role in activation and differentiation of the B-cell.



